Catalyst Wire Dossier Catalyst Wire Dossier

Aczone Gel 7.5%

dapsone topical · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aczone Gel 7.5%, covering 2022-07-27 to 2022-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color [Phase 4]

See pricing